reports
Aktionärinnen und Aktionäre von Cembra stimmen allen Anträgen des Verw...
Cembra Money Bank AG / Schlagwort(e): Generalversammlung Aktionärinnen und Aktionäre von Cembra stimmen allen Anträgen des Verwaltungsrats zu 24.04.2024 / 15:55 CET/CEST Zürich, 24. April 2024 - Die Generalversammlung 2024 der Schweizer Bank Cembra fand heute in Zürich statt. 304 Aktionärinnen und Aktionäre nahmen an der Versammlung teil. Diese vertraten 14'665’422 Namenaktien (einschliesslich durch den unabhängigen Stimmrechtsvertreter vertretene Aktien) respektive 48.88% des ausgegebenen Aktienkapitals. Alle zur Wahl stehenden Mitglieder des Verwaltungsrats wurden für ei...
Cembra shareholders approve all proposals of the Board of Directors
Cembra Money Bank AG / Key word(s): AGMEGM Cembra shareholders approve all proposals of the Board of Directors 24.04.2024 / 15:55 CET/CEST Zurich, 24 April 2024 – The Annual General Meeting 2024 of the Swiss bank Cembra was held in Zurich today. 304 shareholders attended the meeting, representing 14,665,422 registered shares (including the shares represented by the independent proxy) and 48.88% of the issued share capital, respectively. All members of the Board of Directors proposed for re-election were confirmed for a further one-year term of office: Franco Morra (Chairma...
Edison issues initiation on International Public Partnerships (INPP): ...
Edison Investment Research Limited Edison issues initiation on International Public Partnerships (INPP): Consistently and responsibly delivering 24-Apr-2024 / 14:55 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 24 April 2024 Edison issues initiation on International Public Partnerships (INPP): Consistently and responsibly delivering International Public Partnerships’ (INPP’s) FY23 results show that it continues to deliver consistent and predictable returns for investors, while delivering environmental and social benefits for th...
EQS-News: XTPL baut industriellen Prototyp eines Geräts zusammen mit f...
Emittent / Herausgeber: XTPL S.A. / Schlagwort(e): Sonstiges XTPL baut industriellen Prototyp eines Geräts zusammen mit führendem chinesischen Hersteller von Maschinen für die Flachbildschirm-Branche 24.04.2024 / 16:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. XTPL führt derzeit den fünften Verkauf eines Moduls für industrielle Umsetzung durch. Beim Endkunden handelt es sich um einen führenden chinesischen Hersteller von Maschinen für die Flachbildschirm-Branche. Die Geschäftsbeziehung von XTPL mit dem Kunden kam durch die Vermi...
Cue Biopharma to Present at the 2024 American Society of Clinical Onco...
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced today that it will present an oral abstract and poster at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, IL. The presentations will highlight the Company’s Phase 1 trials of its lead interleukin 2 (IL-2)-based biologics,...
Neogen Corp: 1 director
A director at Neogen Corp bought 17,477 shares at 12.090USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
Immunocore announces upcoming presentation and posters at ASCO 2024
Immunocore announces upcoming presentation and posters at ASCO 2024 Immunocore announces upcoming presentation and posters at ASCO 2024 Phase 1 expansion data in immune checkpoints pre-treated cutaneous melanoma for brenetafusp (IMC-F106C targeting PRAME) to be presented during oral abstract session (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 24 April 2024) , a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, w...
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO A...
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data selected for rapid oral session presentation MCLA-145 as monotherapy or in combination with pembrolizumab in solid tumors initial interim clinical data selected for rapid oral session presentation MCLA-129 in NSCLC with c-MET exon 14 skipping mutations initial interim clinical data selected for poster presentation UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MRUS) (Me...
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010...
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting BERKELEY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstracts have been accepted for poster presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 31-June 4, 2024 in Chicago, Illinois. The ANTLER poster will provide initial d...
Morgan Stanley Names 10 Women and an Ally as their MAKERS Class of 202...
NEW YORK--(BUSINESS WIRE)-- Morgan Stanley Wealth Management today named 11 outstanding professionals as part of its partnership with MAKERS – an initiative dedicated to celebrating the stories of leaders who are drivers and champions of women’s achievements. “At Morgan Stanley, we believe it’s important to share and celebrate the stories of our leaders who are committed to advancing women, mentoring and breaking barriers. The MAKERS program, a powerful tradition at our Firm, does just that. We are inspired by this year’s MAKERS class and their incredible commitment to our Firm, clients and ...
Canon Solutions America’s University Inkjet Program Marks Five Years o...
Canon Solutions America’s University Inkjet Program Marks Five Years of Providing Students Real-World Experience District Photo, a Canon Solutions America ProStream customer, hosts students from the program MELVILLE, N.Y., April 24, 2024 (GLOBE NEWSWIRE) -- Providing real-world experience to complement classroom instruction can bring classroom learning to life and give students insight into what a career in the printing industry would be like. Canon Solutions America, a wholly owned subsidiary of Canon U.S.A., Inc., continues to support programs with this sentiment in mind, including th...
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Pr...
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting SOUTH SAN FRANCISCO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced the acceptance of two abstracts for poster presentation at the American Society of Cancer Oncology (“ASCO”), which will be held in Chicago from May 31-June 4, 2024. Session titles and information for the two abstracts are listed bel...
Abstract for longer-term follow-up and additional data analysis of Piv...
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that the abstract for longer-term follow-up and additional data analysis from the pivotal Phase 2 FELIX study of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult B-cell Acute Lymphoblastic Leukemia (ALL) was ...
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combina...
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024 - Final results of CORE-001 Phase 2 trial of cretostimogene in combination with pembrolizumab for the treatment of BCG-unresponsive NMIBC - IRVINE, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that an abstract with final results of CORE-001, its Phase 2 trial of cr...
Director/PDMR Shareholding
Director/PDMR Shareholding 24 April 2024 OSB GROUP PLC (the Company) Notification of Transactions of Persons Discharging Managerial Responsibilities (PDMRs) The Company was notified that Jason Elphick (a PDMR) purchased and sold 10,039 ordinary shares of £0.01 each of the Company. The following notification made under Article 19 of the UK Market Abuse Regulation ("UK MAR") relates to a transaction by a PDMR in the shares of the Company. 1. Details of the person discharging managerial responsibilities / person closely associated Name of natural personJason Elphick2. Reason for...
Correction to stock exchange release: Siili Solutions Plc: Business re...
Correction to stock exchange release: Siili Solutions Plc: Business review, 1 January – 31 March 2024 Correction to stock exchange release: Siili Solutions Plc: Business review, 1 January – 31 March 2024 Siili Solutions Plc Stock exchange release 24 April 2024 at 16:55 This is a correction to the stock exchange release published by Siili Solutions Plc on 24 April 2024 at 9:45 am by which the company published its business review for the period 1 January – 31 March 2024. In section “Key events for January-March” it was stated that “75% of Siili employees have completed a GenAI cert...
Korjaus pörssitiedotteeseen: Siili Solutions Oyj: Liiketoimintakatsaus...
Korjaus pörssitiedotteeseen: Siili Solutions Oyj: Liiketoimintakatsaus 1.1.-31.3.2024 Korjaus pörssitiedotteeseen: Siili Solutions Oyj: Liiketoimintakatsaus 1.1.-31.3.2024 Siili Solutions Oyj Pörssitiedote 24.4.2024 kello 16.55 Tämä on korjaus Siili Solutions Oyj:n 24.4.2024 kello 9.45 julkistamaan pörssitiedotteeseen, jolla julkistettiin yhtiön liiketoimintakatsaus katsauskaudelta 1.1.-31.3.2024. Tiedotteessa kohdassa ”Tammi-maaliskuun tärkeimmät tapahtumat” kerrottiin, että “75 % Siilin työntekijöistä suoritti GenAI-sertifikaatin”. Oikea tieto on, että “51 % Siilin Suomen ...
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Markus Henriksson
- Viktor Stenlöf
Society Pass Inc. Issues First Advance Notice to Strattners Bank, to C...
Society Pass Inc. Issues First Advance Notice to Strattners Bank, to Continue its Growth Plans SINGAPORE, April 24, 2024 (GLOBE NEWSWIRE) -- Society Pass Inc. (SoPa), a leading e-commerce ecosystem in Southeast Asia (SEA), announces its first drawdown on a financing line to continue its growth journey. Following the recent securing of an equity line of up to $40 million, to support Society Pass’s plans for potential public offerings of its subsidiaries, SoPa has issued its first advance notice to Strattners FZCO, the Family Office of Strattners Bank SA. The notice entails the issuance o...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.